Literature DB >> 21460506

Comparison of clinical severity score indices for Clostridium difficile infection.

Shigeki Fujitani1, W Lance George, A Rekha Murthy.   

Abstract

OBJECTIVE: To compare 8 severity score indices for Clostridium difficile infection (CDI).
DESIGN: Prospective observational study.
METHODS: This study was conducted from July through October 2006. All hospitalized patients in 3 university-affiliated hospitals with a positive fecal Clostridium difficile toxin assay result were evaluated. Infection was considered severe if patients had at least 1 of the following clinical events during their hospitalization: (1) death attributed to CDI within 30 days after diagnosis, (2) colectomy necessitated by CDI, or (3) intensive care unit admission for management of complications attributed to CDI. Severity was assessed on the basis of 8 severity score indices, using published criteria for severe CDI as the benchmark. The 8 severity score indices studied were Beth Israel, University of Pittsburgh Medical Center version 1, University of Pittsburgh Medical Center version 2, Hines VA, modified University of Illinois, University of Calgary version 1, University of Calgary version 2, and University of Temple.
RESULTS: Of 184 patients with CDI evaluated, 19 had severe cases and 165 had nonsevere cases, as assessed on the basis of the defined severe CDI criteria. Sensitivities of the 8 severity score indices studied ranged from 63.2% to 84.2%, and specificities ranged from 59.4% to 93.9%. The Hines VA index had the highest kappa score (0.69 [95% confidence interval, 0.54-0.83]), followed by the University of Pittsburgh Medical Center version 1 index. Independent risk factors for severe CDI determined by multivariate analysis were abdominal distention (P = .007), fever (temperature, 38.0°C or above; P = .042), white blood cell count of at least 20,000 cells/mm(3) (P = .035), and hypoalbuminemia (serum albumin level less than 3 mg/dL; P = .029).
CONCLUSION: The Hines VA CDI severity score index appeared to display the strongest correlation for predicting more severe forms of CDI.

Entities:  

Mesh:

Year:  2011        PMID: 21460506     DOI: 10.1086/658336

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  48 in total

1.  Fulminant Clostridium difficile infection: An association with prior appendectomy?

Authors:  Jesse Clanton; Michael Subichin; Katherine Drolshagen; Timothy Daley; Michael S Firstenberg
Journal:  World J Gastrointest Surg       Date:  2013-08-27

2.  Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors.

Authors:  L Sabau; A Meybeck; J Gois; P Devos; P Patoz; N Boussekey; P-Y Delannoy; A Chiche; H Georges; O Leroy
Journal:  Infection       Date:  2013-06-19       Impact factor: 3.553

3.  Assessment of severity of Clostridium difficile infection.

Authors:  Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

4.  Clostridium difficile infection: risk factors, diagnosis and management.

Authors:  Christina M Surawicz
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

Review 5.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

6.  Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Phillip I Tarr; David B Haslam
Journal:  J Pediatr       Date:  2013-09-04       Impact factor: 4.406

Review 7.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 8.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

9.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Elena Deych; Carlos Gonzalez; Phillip I Tarr; David B Haslam
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

10.  Clinical factors associated with development of severe-complicated Clostridium difficile infection.

Authors:  Raina Shivashankar; Sahil Khanna; Patricia P Kammer; W Scott Harmsen; Alan R Zinsmeister; Larry M Baddour; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-20       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.